Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity

被引:162
|
作者
Gille, L [1 ]
Nohl, H [1 ]
机构
[1] VET UNIV VIENNA,INST PHARMACOL & TOXICOL,A-1210 VIENNA,AUSTRIA
关键词
adriamycin; adriamycin aglycone; heart mitochondria; liver mitochondria; exogenous NADH dehydrogenase; semiquinones; oxygen radicals; free radicals;
D O I
10.1016/S0891-5849(97)00025-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular basis of the adriamycin(AQ)-dependent development of cardiotoxicity is still far from being clear. In contrast to our incomplete understanding of the organ-specific mechanism mitochondria are unequivocally accepted as the locus where the molecular disorder is triggered. A growing number of reports intimate the establishment of unbalanced oxygen activation through heart mitochondria in the presence of anthraquinones. In fact, in contrast to liver mitochondria, isolated heart mitochondria have been unequivocally shown to shuttle single electrons to AQ, giving rise to O-2(.-) formation by autoxidizing AQ(.) semiquinones. Earlier we have demonstrated the involvement of the exogenous NADH dehydrogenase in this deleterious electron deviation from the respiratory chain. This enzyme that is associated with complex I of the respiratory chain catalyzes the oxidation of cytosolic NADH. AQ activation through isolated heart mitochondria was reported to require the external addition of NADH, suggesting a flux of reducing equivalents from NADH to AQ in the cytosol. Unlike heart mitochondria, intact liver mitochondria, which are lacking this NADH-related pathway of reducing equivalents from the cytosol to the respiratory chain, cannot be made to activate AQ to semiquinones by NADH or any other substrate of respiration. It appears, therefore, that the exogenous NADH dehydrogenase of heart mitochondria exerts a key function in the myocardial toxicogenesis of anthraquinones via oxygen activation through semireduced AQ. Assessing the toxicological significance of the exogenous NADH dehydrogenase in AQ-related heart injury requires analysis of reaction products and their impact on vital bioenergetic functions, such as energy gain from the oxidation of respiratory substrates. We have applied ESR technique to analyze the identity and possible interactions of radical species emerging from NADH-respiring heart mitochondria in the presence of AQ. The following metabolic steps occur causing depression of energy metabolism in the cardiac tissue. After one-electron transfer to the parent hydrophilic anthraquinone molecule destabilization of the radical formed causes cleavage of the sugar residue. Accumulation of the lipophilic aglycone metabolite in the inner mitochondrial membrane diverts electrons from the regular pathway to electron accepters out of sequence such as H2O2. HO. radicals are formed and affect the functional integrity of energy-linked respiration. The key and possibly initiating role of the exogenous NADH dehydrogenase of cardiac mitochondria in this reaction pathway provides a rationale to explain the selective cardiotoxic potency of the cytostatic anthraquinone glycosides. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:775 / 782
页数:8
相关论文
共 50 条
  • [31] Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo
    Sankarganesh Arunachalam
    Sun Young Kim
    Sun Hwa Lee
    Young Hee Lee
    Min Sun Kim
    Bong Sik Yun
    Ho Keun Yi
    Pyoung Han Hwang
    [J]. Journal of Natural Medicines, 2012, 66 : 149 - 157
  • [32] Protective effects and mechanisms of lycorine against adriamycin-induced cardiotoxicity
    Wang, Zheng
    Chen, Ying
    Gu, Mingming
    Wu, Zhen
    Ding, Baoping
    Yang, Wenwen
    Wu, Xue
    Wang, Changyu
    Gao, Xuhui
    Yang, Yang
    Yin, Guilin
    [J]. PHYTOMEDICINE, 2022, 102
  • [33] Pre-administration of docetaxel inhibits adriamycin-induced cardiotoxicity
    Tomonari, Mari
    To, Hideto
    Sasaki, Hitoshi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 181P - 181P
  • [34] IS MYOCARDITIS A FREQUENT PATHOLOGICAL FINDING IN PATIENTS WITH ADRIAMYCIN-INDUCED CARDIOTOXICITY
    DENOFRIO, D
    STEENBERGEN, C
    GRADY, TA
    MCNULTY, SE
    OCONNOR, CM
    [J]. CLINICAL RESEARCH, 1994, 42 (02): : A168 - A168
  • [35] INHIBITORS OF ADRIAMYCIN-INDUCED HISTAMINE-RELEASE INVITRO LIMIT ADRIAMYCIN CARDIOTOXICITY INVIVO
    KLUGMANN, FB
    DECORTI, G
    CANDUSSIO, L
    GRILL, V
    MALLARDI, F
    BALDINI, L
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (05) : 743 - 748
  • [36] SYSTOLIC-TIME INTERVALS IN MONITORING ADRIAMYCIN-INDUCED CARDIOTOXICITY
    BALCERZAK, SP
    CHRISTAKIS, J
    LEWIS, RP
    OLSON, HM
    MALSPEIS, L
    [J]. CANCER TREATMENT REPORTS, 1978, 62 (06): : 893 - 899
  • [37] Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo
    Arunachalam, Sankarganesh
    Kim, Sun Young
    Lee, Sun Hwa
    Lee, Young Hee
    Kim, Min Sun
    Yun, Bong Sik
    Yi, Ho Keun
    Hwang, Pyoung Han
    [J]. JOURNAL OF NATURAL MEDICINES, 2012, 66 (01) : 149 - 157
  • [38] Cardioprotective mechanisms of melatonin against adriamycin-induced cardiotoxicity in rats
    Kim, N
    Van Cuong, D
    Kim, E
    Han, J
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 292 - 292
  • [39] Melatonin protects the heart against adriamycin-induced cardiotoxicity.
    Liu, X
    Chen, Z
    Hamdy, RC
    Chua, BHL
    [J]. FASEB JOURNAL, 2000, 14 (04): : A120 - A120
  • [40] ANTIOXIDATIVE ACTIVITY OF BENZYLIDENEASCORBATE AND ITS EFFECT ON ADRIAMYCIN-INDUCED CARDIOTOXICITY
    KOJIMA, S
    IIZUKA, H
    YAMAGUCHI, H
    TANUMA, S
    KOCHI, M
    UENO, Y
    [J]. ANTICANCER RESEARCH, 1994, 14 (5A) : 1875 - 1880